The shortage with demand outstripping supply is completely synthetic, because the DEA limits how much amphetamine (and other schedule 2 drugs) may be produced/sold each year and it is completely independent of the US population or the rate that the drugs are prescribed. It is a wholly synthetic limitation of supply.